4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-087487
Chief Technical Officer sold 16,781 shares at $105.30 ($1,767,006)
- Chief Technical Officer acquired 16,781 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shulman Joseph Chief Technical Officer | 2025-09-02 | Option exercise 10b5-1 | +2,094 | $27.35 | $57,271 | 10,603 | D |
| Shulman Joseph Chief Technical Officer | 2025-09-02 | Option exercise 10b5-1 | +14,687 | $30.66 | $450,303 | 25,290 | D |
| Shulman Joseph Chief Technical Officer | 2025-09-02 | Sale 10b5-1 | −16,781 | $105.30 | $1,767,006 | 8,509 | D |
| Derivatives | |||||||
| Shulman Joseph Chief Technical Officer | 2025-09-02 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −2,094 | 16,750 | D | ||
| Shulman Joseph Chief Technical Officer | 2025-09-02 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −14,687 | 22,813 | D | ||
| Open-market sales · 16,781 sh · avg $105.30 · $1,767,006 | |||||||
Loading xslF345X05/tm2525191-1_4seq1.xml…